FDA approves Medtronic PulseSelect pulsed field ablation system

The Medtronic (NYSE:MDT) PulseSelect Pulsed Field Ablation System is the first PFA technology approved for use in the U.S. to treat AFib.

Related Keywords

Boston , Massachusetts , United States , Rebecca Seidel , Medtronic Pulseselect , Ablation Solutions , Medtronic , Boston Scientific , Boston Scientific Farapulse , Investor Day ,